High-Touch Strategy for Lung Cancer Screening

LL
Overseen ByLisa Lowenstein, PHD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: M.D. Anderson Cancer Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The goal of this research study is to compare two different ways to increase lung cancer screening rates for tobacco quitline clients.

Who Is on the Research Team?

LL

Lisa Lowenstein, PHD

Principal Investigator

UT MD Anderson

Are You a Good Fit for This Trial?

Inclusion Criteria

I am between 50 and 80 years old and have smoked for at least 20 pack-years.
I am an adult working in healthcare and can speak English.
I am an adult involved with a tobacco quitline or related organization and speak English.

Exclusion Criteria

I am an adult involved with the quitline or healthcare community.

What Are the Treatments Tested in This Trial?

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Group I: INT: Intervention - High-Touch Strategy: LCS Educational Resources, Decision Coaching, NavigationExperimental Treatment1 Intervention
Group II: CMP: Comparator - Low-Touch Strategy (Usual Practice): LCS Educational ResourcesExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

M.D. Anderson Cancer Center

Lead Sponsor

Trials
3,107
Recruited
1,813,000+